Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Report of ThromboSol efficacy presented at hematology congress

Jan. 9, 1998

BioChem Pharma/Scriptgen conclude licensing and equity agreements

Jan. 8, 1998

Drug discovery collaboration established by Aurora and Merck

Jan. 7, 1998

CIMA terminates one and initiates another OraSolv agreement

Jan. 2, 1998

Genetronics develops new transdermal delivery method suitable for large molecules and genes

Dec. 30, 1997

Bayer/Genzyme drug discovery collaboration

Dec. 24, 1997

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

Dec. 22, 1997

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.